TY  - GEN
AU  - Schetelig,J
AU  - Bornhäuser,M
AU  - Kiehl,M
AU  - Schwerdtfeger,R
AU  - Kröger,N
AU  - Runde,V
AU  - Zabelina,T
AU  - Held,T K
AU  - Thiede,C
AU  - Fauser,A A
AU  - Beelen,D
AU  - Zander,A
AU  - Ehninger,G
AU  - Siegert,W
TI  - Reduced-intensity conditioning with busulfan and fludarabine with or without antithymocyte globulin in HLA-identical sibling transplantation--a retrospective analysis
SN  - 0268-3369
PY  - 2004///0928
KW  - Acute Disease
KW  - Adult
KW  - Aged
KW  - Antilymphocyte Serum
KW  - administration & dosage
KW  - Busulfan
KW  - Chronic Disease
KW  - Combined Modality Therapy
KW  - Female
KW  - Follow-Up Studies
KW  - Graft vs Host Disease
KW  - mortality
KW  - Hematologic Neoplasms
KW  - drug therapy
KW  - Hematopoiesis
KW  - Hematopoietic Stem Cell Transplantation
KW  - Histocompatibility Testing
KW  - Humans
KW  - Immunosuppressive Agents
KW  - Incidence
KW  - Male
KW  - Middle Aged
KW  - Recurrence
KW  - Retrospective Studies
KW  - Siblings
KW  - Survival Analysis
KW  - Transplantation Conditioning
KW  - methods
KW  - Transplantation, Homologous
KW  - Treatment Failure
KW  - Vidarabine
N1  - Publication Type: Journal Article; Research Support, Non-U.S. Gov't
UR  - https://doi.org/10.1038/sj.bmt.1704384
ER  -